Publication alert: The identification of long non-coding RNA locus MYNRL15 shows novel therapeutic potential in AMLs with various genetic backgrounds.
Prof. Dirk Heckl takes on a new position and joins the rest of the leukemia research team in Frankfurt.
In this commentary Dr. Uckelmann and Prof. Klusmann point out recent findings that highlight the therapeutic potential of cotargeting IRAK1 and IRAK4.
The lab members made their way to the dkfz in Heidelberg to take part in the 11th International Symposium on Stem Cell and Cancer to present their latest work.
Prof. Klusmann was awarded with a membership of the Leopoldina, Germany's National Academy of Sciences.
In our commentary we highlight a special case of refractory AML, which went into complete remission after Influenza A infection.
Today the work of our PostDoc Dr. Hasan Issa and colleagues was publishe in Leukemia. It presents the anti-leukemic effects of microRNA-193b-3p and its clincial potential.
Last week, the members of the leukemia research group made their way to Wilsede for the annual Kind-Philip-Meeting. A four day meeting packed with great invited lectures and insightfull presentations.
Leukemia explained: In the latest episode of the KGU Gesundheitsforum Prof. Jan-Henning Klusmann gives a straightforward explanation to the origins of leukemia and our treatment advances, featuring Stephanie as special guest.
Konstantin presents a talk about his project progress at the 4th Rhein Main Cancer Retreat. Other representatives of AG Klusmann were Leah, Anna-Lena and Stephanie presenting respective posters.